More on CASIF
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.16 |
|
|||
| Open | $0.13 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $0.13 | ||||
| Day Low | $0.13 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 551 | ||||
- Form 6-K CASI Pharmaceuticals, For: Aug 14
- CASI Pharmaceuticals Announces First Half 2026 Business and Financial Results
- Form 6-K CASI Pharmaceuticals, For: Aug 13
- Form 6-K CASI Pharmaceuticals, For: Jul 15
- Form 6-K CASI Pharmaceuticals, For: Jun 29
- Form 25-NSE CASI Pharmaceuticals, Filed by: Nasdaq Stock Market LLC
- Form 6-K CASI Pharmaceuticals, For: Jun 02
- Form SCHEDULE 13D/A CASI Pharmaceuticals, Filed by: He Wei-Wu
- Form 20-F CASI Pharmaceuticals, For: Dec 31
- Form D CASI Pharmaceuticals,
Entities mentioned with CASIF
- 13D | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- FDA | View Related Stories »
- ARK | View Related Stories »
- Show More...
